BioTech IQ
  • Home
  • Podcast
  • Hiring?
  • Blog
  • Contact
Select Page
Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD

Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD

by Ammon Rivera | Apr 29, 2022 | Podcast

  On this episode of BioTech IQ, Ammon Rivera interviews Robert Foster Pharm D, PhD, CEO of Hepion Pharmaceuticals. Robert brings 30 years of experience to this discussion and shares with us details of his background that led him to where he is today. We also...

Recent Posts

  • Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick
  • Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon
  • Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh
  • Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper
  • Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis

Recent Comments

  1. Ammon Rivera on Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?
  2. Andy blidy on Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?

Follow BioTech IQ 

  • Follow
  • Follow
  • Follow
biotech logo black

187 W Main St,
Suite 203
Lehi, UT 84043

Biotech IQ © Copyright 2022. All Rights Reserved